Clinical Trial Update: The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China [Phase 2, Phase 3]

View source ↗

Summary

A pediatric trial evaluating individualized 6-mercaptopurine treatment for acute lymphoblastic leukemia in China across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia Pediatric

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)

Snippet

Sponsor: Wei Zhao | Conditions: Acute Lymphoblastic Leukemia, Pediatric | Phase 2, Phase 3 | Status: UNKNOWN